CD274 and neoplasm: Also, MEK inhibition suppresses directly the immunosuppressive activities of macrophages, T-reg and MDSC cells (30) and enhances the anti-tumor efficacy of chimeric antigen receptor (CAR) modified T cells (31) as well as of antibodies targeting the inhibitory IC molecules such as PD-1, PD-L1 and CTLA4 (32).